bibibi.ccLoading…
Connect scattered updates into a story you can understand.
According to Beating AI, Formation Bio has established a 600000000 USD fund and plans over the next 3 to 5 years to acquire or in-license 10 to 15 drug candidate projects, and has already secured licenses for projects.
Moderna CEO said personalized mRNA cancer vaccines could potentially be used for multiple cancers, with kidney cancer trial data potentially released between the end of this year and early next year. Efficacy in other cancer types and production at scale remain to be validated.
Moderna Closes Lower After Early Disclosure of Phase Personalized Cancer Vaccine Data 17.57%, but the trial results remain positive. OpenAI, Anthropic, Nvidia, and Merck KGaA have recently continued to advance their life sciences initiatives.